Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Receives Average Recommendation of “Moderate Buy” from Brokerages
Shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the five analysts that are currently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. The average […]
More Stories
V Square Quantitative Management LLC Purchases 154 Shares of Paychex, Inc. (NASDAQ:PAYX)
V Square Quantitative Management LLC boosted its position in shares of Paychex, Inc. (NASDAQ:PAYX – Free Report) by 2.4% in...
Onyx Bridge Wealth Group LLC Cuts Stake in iShares Russell 2000 ETF (NYSEARCA:IWM)
Onyx Bridge Wealth Group LLC lowered its holdings in shares of iShares Russell 2000 ETF (NYSEARCA:IWM – Free Report) by...
Richard W. Paul & Associates LLC Increases Position in iShares Core MSCI EAFE ETF (BATS:IEFA)
Richard W. Paul & Associates LLC lifted its position in iShares Core MSCI EAFE ETF (BATS:IEFA – Free Report) by...
Orgel Wealth Management LLC Boosts Stake in Vanguard Dividend Appreciation ETF (NYSEARCA:VIG)
Orgel Wealth Management LLC raised its holdings in Vanguard Dividend Appreciation ETF (NYSEARCA:VIG – Free Report) by 18.7% during the...
Richard W. Paul & Associates LLC Sells 218 Shares of Norfolk Southern Co. (NYSE:NSC)
Richard W. Paul & Associates LLC lowered its holdings in Norfolk Southern Co. (NYSE:NSC – Free Report) by 19.5% during...
Richard W. Paul & Associates LLC Has $1.03 Million Stock Holdings in Danaher Co. (NYSE:DHR)
Richard W. Paul & Associates LLC reduced its holdings in shares of Danaher Co. (NYSE:DHR – Free Report) by 1.8%...